Search results
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in ...
Nature· 2 days agoThe article includes two typographical errors, on pages 5 and 6. On page 5, in the sentence beginning with “Dose interruptions…”, and on page 6, in the sentence beginning with “A higher frequency ...
Valuable Guidelines on Prescribing for Patients With Metastatic Breast Cancer in Resource-Scarce...
MedPage Today· 4 days agoStandard-of-care guidelines differ widely from countries with historic access to medical innovation...
...Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the...
Valley City Times Record· 6 days ago...preventative administration of drugs to treat the common side effects of neutropenia and diarrhea...
Case Study: Patient with Rare Breast Cancer Has Surprising Response to NAC
MedPage Today· 3 days agoEach episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient resource. What are the recommended next steps for this 68-year-old woman ...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 3 days agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...
Minimal Residual Disease Testing Progress in Breast Cancer Highlighted at ASCO
GenomeWeb News· 2 days agoRecent advancements in liquid biopsy technologies have rapidly created new testing options for oncologists specializing in breast cancer, most notably personalized ...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 5 days agometastatic urothelial cancer (mUC). Trodelvy (sacituzumab govitecan-hziy) is a first-in-class...
Obituaries in Springfield, MO | News-Leader
The Springfield News-Leader· 10 hours agoGisele was born and raised in Ozark, Missouri, the youngest of Raymond and Gisela Drake’s three daughters. She had a distinguished career that spanned more than three decades at CoxHealth, one of the largest regional health systems in Missouri.
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 3 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...